iodixanol (optiprep Search Results


90
STEMCELL Technologies Inc iodixanol optipreptm
Iodixanol Optipreptm, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/iodixanol optipreptm/product/STEMCELL Technologies Inc
Average 90 stars, based on 1 article reviews
iodixanol optipreptm - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Axis-Shield Diagnostics iodixanol (optiprep
Iodixanol (Optiprep, supplied by Axis-Shield Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/iodixanol (optiprep/product/Axis-Shield Diagnostics
Average 90 stars, based on 1 article reviews
iodixanol (optiprep - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Nycomed iodixanol 40% solution optiprep
Iodixanol 40% Solution Optiprep, supplied by Nycomed, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/iodixanol 40% solution optiprep/product/Nycomed
Average 90 stars, based on 1 article reviews
iodixanol 40% solution optiprep - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Greiner Bio discontinuous gradient of iodixanol
Discontinuous Gradient Of Iodixanol, supplied by Greiner Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/discontinuous gradient of iodixanol/product/Greiner Bio
Average 90 stars, based on 1 article reviews
discontinuous gradient of iodixanol - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Axis-Shield Diagnostics iodixanol was supplied as a 60% w/v solution (optiprep™)
Iodixanol Was Supplied As A 60% W/V Solution (Optiprep™), supplied by Axis-Shield Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/iodixanol was supplied as a 60% w/v solution (optiprep™)/product/Axis-Shield Diagnostics
Average 90 stars, based on 1 article reviews
iodixanol was supplied as a 60% w/v solution (optiprep™) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Greiner Bio iodixanol density gradient optiprep
Iodixanol Density Gradient Optiprep, supplied by Greiner Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/iodixanol density gradient optiprep/product/Greiner Bio
Average 90 stars, based on 1 article reviews
iodixanol density gradient optiprep - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Serumwerk Bernburg AG iodixanol optiprep
Iodixanol Optiprep, supplied by Serumwerk Bernburg AG, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/iodixanol optiprep/product/Serumwerk Bernburg AG
Average 90 stars, based on 1 article reviews
iodixanol optiprep - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
STEMCELL Technologies Inc optiprep 60% iodixanol in water
Optiprep 60% Iodixanol In Water, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/optiprep 60% iodixanol in water/product/STEMCELL Technologies Inc
Average 90 stars, based on 1 article reviews
optiprep 60% iodixanol in water - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Nycomed iodixanol optiprep-nycomed
Iodixanol Optiprep Nycomed, supplied by Nycomed, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/iodixanol optiprep-nycomed/product/Nycomed
Average 90 stars, based on 1 article reviews
iodixanol optiprep-nycomed - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Progen Biotechnik iodixanol optiprep
Alphaherpesvirus gB localizes to EVs-enriched fractions isolated from virus-infected MJS cells and BoHV-1-infected MDBK. OptiPrep gradient-purification of EVs-enriched and virion-enriched fractions from HSV-1-infected MJS ( A ), BoHV-1-infected MJS ( B ), PRV-infected MJS ( C ), and BoHV-1-infected MDBK ( D ) supernatants. MJS cells were infected with HSV-1 at a multiplicity of infection (moi) of 0.1, with BoHV-1/PRV at an moi of 0.5; MDBK cells were infected at an moi of 0.1. After 50 h post-infection, 0.5 mL fractions were collected from 6%–18% <t>iodixanol</t> (Optiprep) gradient by ultracentrifugation. The 40 µL samples were analyzed in denaturing (for viral glycoprotein C-gC, glycoprotein B-gB, glycoprotein D-gD, for HSV-1, glycoprotein E-gE, for BoHV-1 and PRV or EVs marker Alix) or non-denaturing (for EVs markers CD63 and CD9) SDS-PAGE, and immunoblotted with specific mAbs or polyclonal anti-PRV gB serum. Uninfected (Ø) or virus-infected cell lysates (cl) were analyzed as controls. Bottom panels represent virus titres in each fraction measured by plaque assay. ( E ) Proteins from the indicated fractions (40 μL) were separated by SDS-PAGE, and immunoblotted with antibodies specific to the ICP5/VCP5 homolog of HSV-1 and BoHV-1, virulence factor γ34.5 from HSV-1, immunomodulatory UL49.5 protein of BoHV-1 and envelope glycoproteins gD, and gM, as indicated. HLA-DRβ was detected in the fractions as an EVs marker. Cell lysates (cl) and virus-infected cell lysates (30 μg) were analyzed as controls. ( F ) Comparison of HLA-DRβ levels between EVs from virus-infected and uninfected MJS. DRβ and flotillin-2 (flot-2, EVs marker) from F11 fractions were immunoblotted with specific mAb. Numbers indicate the optical density of DRβ bands from virus-infected MJS EVs, normalized to flot-2 from the same samples, relative to DRβ in EVs from uninfected MJS (set as 1).
Iodixanol Optiprep, supplied by Progen Biotechnik, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/iodixanol optiprep/product/Progen Biotechnik
Average 90 stars, based on 1 article reviews
iodixanol optiprep - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Abbott Laboratories iodixanol
Alphaherpesvirus gB localizes to EVs-enriched fractions isolated from virus-infected MJS cells and BoHV-1-infected MDBK. OptiPrep gradient-purification of EVs-enriched and virion-enriched fractions from HSV-1-infected MJS ( A ), BoHV-1-infected MJS ( B ), PRV-infected MJS ( C ), and BoHV-1-infected MDBK ( D ) supernatants. MJS cells were infected with HSV-1 at a multiplicity of infection (moi) of 0.1, with BoHV-1/PRV at an moi of 0.5; MDBK cells were infected at an moi of 0.1. After 50 h post-infection, 0.5 mL fractions were collected from 6%–18% <t>iodixanol</t> (Optiprep) gradient by ultracentrifugation. The 40 µL samples were analyzed in denaturing (for viral glycoprotein C-gC, glycoprotein B-gB, glycoprotein D-gD, for HSV-1, glycoprotein E-gE, for BoHV-1 and PRV or EVs marker Alix) or non-denaturing (for EVs markers CD63 and CD9) SDS-PAGE, and immunoblotted with specific mAbs or polyclonal anti-PRV gB serum. Uninfected (Ø) or virus-infected cell lysates (cl) were analyzed as controls. Bottom panels represent virus titres in each fraction measured by plaque assay. ( E ) Proteins from the indicated fractions (40 μL) were separated by SDS-PAGE, and immunoblotted with antibodies specific to the ICP5/VCP5 homolog of HSV-1 and BoHV-1, virulence factor γ34.5 from HSV-1, immunomodulatory UL49.5 protein of BoHV-1 and envelope glycoproteins gD, and gM, as indicated. HLA-DRβ was detected in the fractions as an EVs marker. Cell lysates (cl) and virus-infected cell lysates (30 μg) were analyzed as controls. ( F ) Comparison of HLA-DRβ levels between EVs from virus-infected and uninfected MJS. DRβ and flotillin-2 (flot-2, EVs marker) from F11 fractions were immunoblotted with specific mAb. Numbers indicate the optical density of DRβ bands from virus-infected MJS EVs, normalized to flot-2 from the same samples, relative to DRβ in EVs from uninfected MJS (set as 1).
Iodixanol, supplied by Abbott Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/iodixanol/product/Abbott Laboratories
Average 90 stars, based on 1 article reviews
iodixanol - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Cosmo Bio USA optiprep 60% w/v aqueous iodixanol
Alphaherpesvirus gB localizes to EVs-enriched fractions isolated from virus-infected MJS cells and BoHV-1-infected MDBK. OptiPrep gradient-purification of EVs-enriched and virion-enriched fractions from HSV-1-infected MJS ( A ), BoHV-1-infected MJS ( B ), PRV-infected MJS ( C ), and BoHV-1-infected MDBK ( D ) supernatants. MJS cells were infected with HSV-1 at a multiplicity of infection (moi) of 0.1, with BoHV-1/PRV at an moi of 0.5; MDBK cells were infected at an moi of 0.1. After 50 h post-infection, 0.5 mL fractions were collected from 6%–18% <t>iodixanol</t> (Optiprep) gradient by ultracentrifugation. The 40 µL samples were analyzed in denaturing (for viral glycoprotein C-gC, glycoprotein B-gB, glycoprotein D-gD, for HSV-1, glycoprotein E-gE, for BoHV-1 and PRV or EVs marker Alix) or non-denaturing (for EVs markers CD63 and CD9) SDS-PAGE, and immunoblotted with specific mAbs or polyclonal anti-PRV gB serum. Uninfected (Ø) or virus-infected cell lysates (cl) were analyzed as controls. Bottom panels represent virus titres in each fraction measured by plaque assay. ( E ) Proteins from the indicated fractions (40 μL) were separated by SDS-PAGE, and immunoblotted with antibodies specific to the ICP5/VCP5 homolog of HSV-1 and BoHV-1, virulence factor γ34.5 from HSV-1, immunomodulatory UL49.5 protein of BoHV-1 and envelope glycoproteins gD, and gM, as indicated. HLA-DRβ was detected in the fractions as an EVs marker. Cell lysates (cl) and virus-infected cell lysates (30 μg) were analyzed as controls. ( F ) Comparison of HLA-DRβ levels between EVs from virus-infected and uninfected MJS. DRβ and flotillin-2 (flot-2, EVs marker) from F11 fractions were immunoblotted with specific mAb. Numbers indicate the optical density of DRβ bands from virus-infected MJS EVs, normalized to flot-2 from the same samples, relative to DRβ in EVs from uninfected MJS (set as 1).
Optiprep 60% W/V Aqueous Iodixanol, supplied by Cosmo Bio USA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/optiprep 60% w/v aqueous iodixanol/product/Cosmo Bio USA
Average 90 stars, based on 1 article reviews
optiprep 60% w/v aqueous iodixanol - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Alphaherpesvirus gB localizes to EVs-enriched fractions isolated from virus-infected MJS cells and BoHV-1-infected MDBK. OptiPrep gradient-purification of EVs-enriched and virion-enriched fractions from HSV-1-infected MJS ( A ), BoHV-1-infected MJS ( B ), PRV-infected MJS ( C ), and BoHV-1-infected MDBK ( D ) supernatants. MJS cells were infected with HSV-1 at a multiplicity of infection (moi) of 0.1, with BoHV-1/PRV at an moi of 0.5; MDBK cells were infected at an moi of 0.1. After 50 h post-infection, 0.5 mL fractions were collected from 6%–18% iodixanol (Optiprep) gradient by ultracentrifugation. The 40 µL samples were analyzed in denaturing (for viral glycoprotein C-gC, glycoprotein B-gB, glycoprotein D-gD, for HSV-1, glycoprotein E-gE, for BoHV-1 and PRV or EVs marker Alix) or non-denaturing (for EVs markers CD63 and CD9) SDS-PAGE, and immunoblotted with specific mAbs or polyclonal anti-PRV gB serum. Uninfected (Ø) or virus-infected cell lysates (cl) were analyzed as controls. Bottom panels represent virus titres in each fraction measured by plaque assay. ( E ) Proteins from the indicated fractions (40 μL) were separated by SDS-PAGE, and immunoblotted with antibodies specific to the ICP5/VCP5 homolog of HSV-1 and BoHV-1, virulence factor γ34.5 from HSV-1, immunomodulatory UL49.5 protein of BoHV-1 and envelope glycoproteins gD, and gM, as indicated. HLA-DRβ was detected in the fractions as an EVs marker. Cell lysates (cl) and virus-infected cell lysates (30 μg) were analyzed as controls. ( F ) Comparison of HLA-DRβ levels between EVs from virus-infected and uninfected MJS. DRβ and flotillin-2 (flot-2, EVs marker) from F11 fractions were immunoblotted with specific mAb. Numbers indicate the optical density of DRβ bands from virus-infected MJS EVs, normalized to flot-2 from the same samples, relative to DRβ in EVs from uninfected MJS (set as 1).

Journal: Viruses

Article Title: Alphaherpesvirus gB Homologs Are Targeted to Extracellular Vesicles, but They Differentially Affect MHC Class II Molecules

doi: 10.3390/v12040429

Figure Lengend Snippet: Alphaherpesvirus gB localizes to EVs-enriched fractions isolated from virus-infected MJS cells and BoHV-1-infected MDBK. OptiPrep gradient-purification of EVs-enriched and virion-enriched fractions from HSV-1-infected MJS ( A ), BoHV-1-infected MJS ( B ), PRV-infected MJS ( C ), and BoHV-1-infected MDBK ( D ) supernatants. MJS cells were infected with HSV-1 at a multiplicity of infection (moi) of 0.1, with BoHV-1/PRV at an moi of 0.5; MDBK cells were infected at an moi of 0.1. After 50 h post-infection, 0.5 mL fractions were collected from 6%–18% iodixanol (Optiprep) gradient by ultracentrifugation. The 40 µL samples were analyzed in denaturing (for viral glycoprotein C-gC, glycoprotein B-gB, glycoprotein D-gD, for HSV-1, glycoprotein E-gE, for BoHV-1 and PRV or EVs marker Alix) or non-denaturing (for EVs markers CD63 and CD9) SDS-PAGE, and immunoblotted with specific mAbs or polyclonal anti-PRV gB serum. Uninfected (Ø) or virus-infected cell lysates (cl) were analyzed as controls. Bottom panels represent virus titres in each fraction measured by plaque assay. ( E ) Proteins from the indicated fractions (40 μL) were separated by SDS-PAGE, and immunoblotted with antibodies specific to the ICP5/VCP5 homolog of HSV-1 and BoHV-1, virulence factor γ34.5 from HSV-1, immunomodulatory UL49.5 protein of BoHV-1 and envelope glycoproteins gD, and gM, as indicated. HLA-DRβ was detected in the fractions as an EVs marker. Cell lysates (cl) and virus-infected cell lysates (30 μg) were analyzed as controls. ( F ) Comparison of HLA-DRβ levels between EVs from virus-infected and uninfected MJS. DRβ and flotillin-2 (flot-2, EVs marker) from F11 fractions were immunoblotted with specific mAb. Numbers indicate the optical density of DRβ bands from virus-infected MJS EVs, normalized to flot-2 from the same samples, relative to DRβ in EVs from uninfected MJS (set as 1).

Article Snippet: The supernatant was diluted with 60% ( w / v ) iodixanol (OptiPrep, Progen Biotechnik, Heidelberg, Germany) to obtain 6%, and loaded on top of ioxidanol-based gradient ranging from 6 to 18%, with a 1.2% increment (11 mL in volume).

Techniques: Isolation, Virus, Infection, Purification, Marker, SDS Page, Plaque Assay, Comparison